SubscribeThe term “specialty drug” refers to high-cost, high-touch medications for patients with diseases such as cancer, multiple sclerosis, rheumatoid arthritis, and other chronic or rare conditions.1,2 Specialty drugs are typically complex to manufacture and often require special handling and administration; [ Read More ]
An Interview with Dawn Holcombe, MBA, FACMPE, ACHE, President, DGH Consulting, South Windsor, CT; Executive Director, Connecticut Oncology Association, South Windsor, CT To discuss the use of specialty pharmacy services, Innovations in Oncology Management™ recently spoke with Dawn Holcombe, President [ Read More ]
Welcome to Innovations in Oncology Management™, a newsletter series that provides concise, up-to-date information on current issues that are impacting the business of oncology. Developed for oncology practice administrators, administrative staff, advanced practice clinicians, and oncology pharmacists, our second newsletter [ Read More ]